Skip to main content
. Author manuscript; available in PMC: 2019 May 18.
Published in final edited form as: Drug Discov Today Dis Models. 2018 May 18;24:13–21. doi: 10.1016/j.ddmod.2018.04.002

Table 1.

Summary of models used for assessing the host response to biomaterials.

Model Advantages Drawbacks
In vitro models Macrophage interrogation of a biomaterial Enables assessment of macrophage activity as a function of biomaterial properties Lacks influence of crosstalk between cell types present in the FBR in vivo
Co-culture of macrophages with other cell types Allows for investigation of paracrine and juxtracrine signaling on macrophage activity Limited to one phase of the FBR
In vivo models Rodent wild-type models Supports assessment of the phases of the FBR over time Limited assessment of redundant immune pathways
Genetically modified mouse models Provides insight into the pathways and cell types that drive the FBR Expensive
Large animal models Demonstrates translatability of mouse models; clinically relevant Expensive; highly regulated